- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Large Cap High Growth Potential
Australian Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
1
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
CSL | AU$280.43 | 3.1% | -6.5% | AU$135.8b | AU$330.04 | PE31.9x | E12.8% | 1.5% |
Page 1 of 1